{"brief_title": "A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia", "brief_summary": "Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa", "condition": ["Schizophrenia"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["olanzapine", "atomoxetine", "placebo"], "criteria": "Inclusion Criteria: - Must have a clinical diagnosis of Schizophrenia - Must be at least 18 years of age and not older than 55 years of age - Must have been stable on a dose of Abilify, Risperdal, Seroquel, or Zyprexa for the past 8 weeks - Women of childbearing potential must be using a medically accepted means of contraception - Must be able to swallow capsules Exclusion Criteria: - Has serious health problems other than Schizophrenia - Takes an antidepressant for depression - Takes insulin for diabetes - Have a history of alcohol or drug dependence (except for nicotine and caffeine) within the past 6 months", "gender": "All", "minimum_age": "18 Years", "maximum_age": "55 Years", "healthy_volunteers": "No", "mesh_term": ["Schizophrenia", "Atomoxetine Hydrochloride", "Olanzapine"], "id": "NCT00089869"}